ConvaTec Group Community

LSE:CTEC Community

1 Narratives written by author
0 Comments on narratives written by author
13 Fair Values set on narratives written by author

AN

AnalystConsensusTarget

Consensus Narrative from 20 Analysts

Robust Product Pipeline And Automation Investments Will Drive Future Market Expansion

Key Takeaways ConvaTec's new product pipeline and market share growth in chronic care categories align well for sustained revenue expansion and innovative market leadership. R&D investments and efficient cost management are set to enhance margins, earnings, and shareholder value, fostering continuous financial performance improvement.

UK£2.95

FV

13.0% undervalued

5.43%

Revenue growth p.a.

0

0

13

5 days ago